DNSP-11buy The DNSP-11 peptide represents a significant development in neuroprotection, particularly for dopamine neurons. This 11-mer peptide, derived from the pro-domain of the human Glial Cell Line-Derived Neurotrophic Factor (GDNF) family, has demonstrated potent neurotrophic and neuroprotective activities. Early research suggests that DNSP-11 is the first peptide from this specific region of GDNF to exhibit in vivo trophic-like actions, positioning it as a promising candidate for therapeutic interventions aimed at neurodegenerative conditions affecting dopaminergic systems. Its ability to support the survival of fetal mesencephalic neurons and protect human dopaminergic neuroblastoma cells against induced cell death highlights its potential to safeguard critical neural pathwaysRelated peptide DNSP-11has more studies. This looks as the simplier and cheaper version of it but still efective. Dynamic changes in ....
DNSP-11 is an 11 amino acid peptide that originates from the pro-GDNF domain.Targeting the hypothalamic a11 nucleus to treat parkinsonian-like ... Specifically, it is a predicted endopeptidase cleavage product from the proregion of human pre-proGDNF. This synthetic, amidated peptide is characterized by its precise sequence, comprising eleven consecutive amino acid residues.作者：K Kelps·被引用次数：1—Here we characterize threepeptides(DNSP-5,DNSP-11, and DNSP-17) to determine it they are stable and offer protective effects similar to GNDF ... Its derivation from a naturally occurring protein precursor underscores a biological rationale for its observed effects. The structure and origin of DNSP-11 are key to understanding its mechanism of action and its potential therapeutic applications.作者：JH Sonne·被引用次数：4—This study provides evidence for a potential easy-to-administer intranasal therapeutic using theDNSP-11 peptidefor protection from a 6-OHDA ...
The primary focus of research surrounding DNSP-11 is its neuroprotective activity toward dopamine neurons. Studies indicate that it can provide protection against cell death induced by agents like staurosporine and 6-hydroxydopamine (6-OHDA). This protective effect is mediated, in part, by the activation of neuroprotective signaling pathways, such as ERK1/2 phosphorylationeffects of intranasally administered dnsp-11 on the central .... Furthermore, DNSP-11 has been shown to influence dopamine neuron function dynamically, suggesting it can modulate neuronal activity and potentially restore or enhance dopaminergic signaling.
Beyond its direct cellular protective effects, the methodology and effects of repeated intranasal delivery of DNSP-11 are being explored as a viable administration routeIn vitro,DNSP-11 supports the survival of fetal mesencephalic neuronsand in vivo, DNSP-11 increases dopamine and dopamine metabolite tissue levels in the .... Intranasal delivery offers a non-invasive approach to bypass the blood-brain barrier, allowing the peptide to reach the central nervous system (CNS) and exert its neuroactive properties. This method has shown promise in maintaining the peptide's efficacy in both normal and disease models, such as those mimicking Parkinson's disease.作者：JL Fuqua·2014·被引用次数：17—... 11-amino-acidpeptidenamed dopamine neuron stimulatingpeptide-11 (DNSP-11). A single treatment ofDNSP-11was delivered to the substantia nigra in the rat ...
The scientific exploration of DNSP-11 continues to expand. Studies have investigated its effects in various models, including in vivo experiments on rats where it has been delivered to the substantia nigra, a critical area for dopamine production.A Synthetic five Amino Acid Pro-peptide increases ... In these studies, DNSP-11 has been observed to increase dopamine and dopamine metabolite tissue levels.
While DNSP-11 is a compelling subject of research, it is important to note its current status as a high-quality, specialized research peptideAmidated dopamine neuron stimulating peptides for cns .... Further investigation is needed to fully elucidate its therapeutic potential and safety profile for clinical applicationseffects of intranasally administered dnsp-11 on the central .... However, its demonstrated neurotrophic and neuroprotective actions, coupled with promising delivery methods, position DNSP-11 as a significant area of interest for future advancements in treating neurological disorders characterized by dopamine neuron degeneration.
Join the newsletter to receive news, updates, new products and freebies in your inbox.